AP2007004022A0 - Enhancer of the effect of adrenocorticoid, comprising gum arabic - Google Patents

Enhancer of the effect of adrenocorticoid, comprising gum arabic

Info

Publication number
AP2007004022A0
AP2007004022A0 AP2007004022A AP2007004022A AP2007004022A0 AP 2007004022 A0 AP2007004022 A0 AP 2007004022A0 AP 2007004022 A AP2007004022 A AP 2007004022A AP 2007004022 A AP2007004022 A AP 2007004022A AP 2007004022 A0 AP2007004022 A0 AP 2007004022A0
Authority
AP
ARIPO
Prior art keywords
adrenocorticoid
enhancer
effect
gum arabic
arabic
Prior art date
Application number
AP2007004022A
Other languages
English (en)
Inventor
Yumiko Kubo
Michinori Kubo
Hideaki Matsuda
Original Assignee
Veritron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veritron Ltd filed Critical Veritron Ltd
Publication of AP2007004022A0 publication Critical patent/AP2007004022A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AP2007004022A 2004-11-30 2005-11-29 Enhancer of the effect of adrenocorticoid, comprising gum arabic AP2007004022A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004346673 2004-11-30
PCT/JP2005/022267 WO2006059764A2 (fr) 2004-11-30 2005-11-29 Amplificateur de l'effet d'un adrenocorticoide, contenant de la gomme arabique

Publications (1)

Publication Number Publication Date
AP2007004022A0 true AP2007004022A0 (en) 2007-06-30

Family

ID=36250826

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007004022A AP2007004022A0 (en) 2004-11-30 2005-11-29 Enhancer of the effect of adrenocorticoid, comprising gum arabic

Country Status (17)

Country Link
US (1) US20090060944A1 (fr)
EP (1) EP1817040A2 (fr)
JP (1) JP2008521791A (fr)
KR (1) KR20070084588A (fr)
CN (1) CN101232889A (fr)
AP (1) AP2007004022A0 (fr)
AU (1) AU2005310453A1 (fr)
BR (1) BRPI0518712A2 (fr)
CA (1) CA2584136A1 (fr)
IL (1) IL182951A0 (fr)
MA (1) MA29105B1 (fr)
MX (1) MX2007006365A (fr)
NO (1) NO20073379L (fr)
RU (1) RU2007124549A (fr)
TW (1) TW200631590A (fr)
WO (1) WO2006059764A2 (fr)
ZA (1) ZA200704404B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200803883A (en) * 2005-09-22 2008-01-16 Veritron Ltd Enhancer of cholinesterase activity
DE102006061517A1 (de) * 2006-12-18 2008-06-19 Eberhard-Karls-Universität Tübingen Universitätsklinikum Angioinhibin
DE102007039310A1 (de) * 2007-08-13 2009-02-19 Eberhard-Karls-Universität Tübingen Universitätsklinikum Zusammensetzung zur Prophylaxe und Behandlung von Osteoporose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB841998A (en) * 1956-11-28 1960-07-20 Merck & Co Inc Steroid compounds
US5554386A (en) * 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides

Also Published As

Publication number Publication date
US20090060944A1 (en) 2009-03-05
TW200631590A (en) 2006-09-16
MX2007006365A (es) 2007-06-20
NO20073379L (no) 2007-06-29
IL182951A0 (en) 2007-09-20
KR20070084588A (ko) 2007-08-24
MA29105B1 (fr) 2007-12-03
WO2006059764A3 (fr) 2007-04-19
BRPI0518712A2 (pt) 2008-12-02
AU2005310453A1 (en) 2006-06-08
ZA200704404B (en) 2008-08-27
EP1817040A2 (fr) 2007-08-15
WO2006059764A2 (fr) 2006-06-08
CN101232889A (zh) 2008-07-30
CA2584136A1 (fr) 2006-06-08
RU2007124549A (ru) 2009-01-10
JP2008521791A (ja) 2008-06-26

Similar Documents

Publication Publication Date Title
IL177968A0 (en) Tetrahydropyridoindole derivatives
EP1748891A4 (fr) Bandes d'etancheite
GB0414272D0 (en) OsK1 derivatives
GB0414595D0 (en) Aqueous composition II
AU303347S (en) Cap
GB0516704D0 (en) Wheel structure
GB0516481D0 (en) Trailers
GB0404714D0 (en) Secure printing
GB0701803D0 (en) Bacteriar eliminator
IL179444A0 (en) 4-phenyl-pyrimidine-2-carbonitrile derivatives
IL182951A0 (en) Enhancer of the effect of adrenocorticoid, comprising gum arabic
GB2420586B (en) Fastening
SG114746A1 (en) Stabilized hydroxypivalaldehyde
HK1107280A (en) Enhancer of the effect of adrenocorticoid, comprising gum arabic
GB0418583D0 (en) Windbreaks
EP1828017A4 (fr) Couverture de transport
GB0402606D0 (en) Printing
AU3711P (en) Sunbelle Sensation Blandfordia grandiflora
AU156636S (en) Wheel
AU156893S (en) Wheel
AU156892S (en) Wheel
AU156891S (en) Wheel
AU156738S (en) Wheel
HU0400211D0 (en) Anti-skidding application
GB0425100D0 (en) Wheel aid